Genetic polymorphisms in NFKBIA have attracted much interest due to their potential role in the etiology and outcomes of Hodgkin’s lymphoma, colorectal cancer, melanoma, hepatocellular carcinoma, breast cancer and multiple myeloma (25–37). Here, NFKBIA is linked to plasma cell myeloma.